Christine E. Thomas - Oct 10, 2023 Form 4 Insider Report for FEMASYS INC (FEMY)

Role
SVP, Regulatory & Clinical
Signature
/s/ Kathy Lee-Sepsick, Attorney-in-fact
Stock symbol
FEMY
Transactions as of
Oct 10, 2023
Transactions value $
$0
Form type
4
Date filed
11/1/2023, 09:40 PM
Previous filing
Oct 17, 2022
Next filing
Feb 2, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FEMY Stock Option (Right to Buy) Award $0 +60K $0.00 60K Oct 10, 2023 Common Stock 60K $1.76 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying the stock option vest equally in installments over 4 years beginning on October 10, 2024, provided that the reporting person is employed by the Issuer or a subsidiary of the Issuer on the vesting date.